News Industry News Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure October 27, 2015
News Features Opportunities Exist for Hospitals, Interventionalists to Stave Off Unnecessary Readmissions July 28, 2015
News Daily News MVARC Document Offers Template for Mitral Valve Therapeutics Research Todd Neale July 16, 2015
News Industry News Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan) July 07, 2015
News Industry News Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease June 05, 2015
News Industry News Clinical Trial Demonstrates Elevated Thymosin Beta 4 Plasma Levels are Associated with Improvement of Symptoms After Stem Cell Therapy in Patients with Ischemic Heart Failure June 02, 2015
News Industry News Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies May 28, 2015
News Daily News La IC Empeora los Resultados Post-SCA No observándose Beneficio alguno con Apixaban Todd Neale January 28, 2015
News Daily News HF Worsens Outcomes Following ACS, With No Benefit From Apixaban Todd Neale January 28, 2015
News Daily News Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk L.A. McKeown June 03, 2011
News Daily News Researchers Accurately Predict Who Will Discontinue Clopidogrel Jason Kahn January 09, 2011